DOT updates and changes!

Oct 5, 2017 | Industry News

dot drug testing updates

Last month (8/8/17) the Department of Transportation’s Office of Management and Budget approved a new/revised Federal Drug Testing Custody and Control Form (CCF).

What does this mean for the DOT drug testing program?

They authorized the continued use of the ‘old’ CCF until June 30, 2018. DOT regulated employers and their service agents (collectors, laboratories, Medical Review Offices) should continue using the ‘old’ CCF until further notice.

A “memorandum for the record” is not required while using the ‘old’ CCF.

What’s the difference between the revised and ‘old’ CCF?

The revised CCF includes the following changes:

In Step 1D:

  • Removal of the checkbox, the letters “DOT” and hash line in front of the text “Specify DOT Agency”

In Step 5A:

  • Addition of four new analytes (oxycodone, oxymorphone, hydrocodone, and hyrdromorphone)
  • Removal of the analyte methylenedioxyethylamphetamine (MDEA).

Can DOT regulated employers and their service agents us the approved revised CCF for testing under 49 CFR Part 40?

Not at this time because DOT has not issued a final rule authorizing testing for synthetic opioids.

You can view these updated rules on the DOT website here.